Safranal, an active ingredient of saffron, attenuates cognitive deficits in amyloid β-induced rat model of Alzheimer’s disease: underlying mechanisms

被引:0
作者
Tourandokht Baluchnejadmojarad
Seyed-Mahdi Mohamadi-Zarch
Mehrdad Roghani
机构
[1] Iran University of Medical Sciences,Department of Physiology, School of Medicine
[2] Shahed University,Neurophysiology Research Center
来源
Metabolic Brain Disease | 2019年 / 34卷
关键词
Alzheimer’s disease; Amyloid β; Safranal; Learning and memory; Oxidative stress; Inflammation;
D O I
暂无
中图分类号
学科分类号
摘要
Alzheimer’s disease (AD) is the most prevalent neurodegenerative amyloid disorder with progressive deterioration of cognitive and memory skills. Despite many efforts, no decisive therapy yet exists for AD. Safranal is the active constituent of saffron essential oil with antioxidant, anti-inflammatory, and anti-apoptotic properties. In this study, the possible beneficial effect of safranal on cognitive deficits was evaluated in a rat model of AD induced by intrahippocampal amyloid beta (Aβ1–40). Safranal was daily given p.o. (0.025, 0.1, and 0.2 ml/kg) post-surgery for 1 week and finally learning and memory were evaluated in addition to assessment of the involvement of oxidative stress, inflammation, and apoptosis. Findings showed that safranal treatment of amyloid β-microinjected rats dose-dependently improved cognition in Y-maze, novel-object discrimination, passive avoidance, and 8-arm radial arm maze tasks. Besides, safranal attenuated hippocampal level of malondialdehyde (MDA), reactive oxygen species (ROS), protein carbonyl, interleukin 1β (IL-1β), interleukin 6 (IL-6), tumor necrosis factor α (TNFα), nuclear factor-kappa B (NF-kB), apoptotic biomarkers including caspase 3 and DNA fragmentation, glial fibrillary acidic protein (GFAP), myeloperoxidase (MPO), and acetylcholinesterase (AChE) activity and improved superoxide dismutase (SOD) activity and mitochondrial membrane potential (MMP) with no significant effect on nitrite, catalase activity, and glutathione (GSH). Furthermore, safranal prevented CA1 neuronal loss due to amyloid β1–40. In summary, safranal treatment of intrahippocampal amyloid beta1–40-microinjected rats could prevent learning and memory decline via neuronal protection and at a molecular level through amelioration of apoptosis, oxidative stress, inflammation, cholinesterase activity, neutrophil infiltration, and also by preservation of mitochondrial integrity.
引用
收藏
页码:1747 / 1759
页数:12
相关论文
共 50 条
  • [41] Trigonelline protects hippocampus against intracerebral A(1-40) as a model of Alzheimer's disease in the rat: insights into underlying mechanisms
    Fahanik-Babaei, Javad
    Baluchnejadmojarad, Tourandokht
    Nikbakht, Farnaz
    Roghani, Mehrdad
    METABOLIC BRAIN DISEASE, 2019, 34 (01) : 191 - 201
  • [42] Amelioration of amyloid-β-induced deficits by DcR3 in an Alzheimer’s disease model
    Yi-Ling Liu
    Wei-Ting Chen
    Yu-Yi Lin
    Po-Hung Lu
    Shie-Liang Hsieh
    Irene Han-Juo Cheng
    Molecular Neurodegeneration, 12
  • [43] (3-Sitosterol ameliorates the cognitive deficits and neuropathological hallmarks in an Alzheimer's disease model
    Sajad, Mohd
    Ali, Rafat
    Kumar, Rajesh
    Khan, Nida Jamil
    Wahab, Shadma
    Alshehri, Saad Ali
    Thakur, Sonu Chand
    ARABIAN JOURNAL OF CHEMISTRY, 2025, 18 (01)
  • [44] Antidepressant agomelatine attenuates behavioral deficits and concomitant pathology observed in streptozotocin-induced model of Alzheimer's disease in male rats
    Ilieva, Kalina
    Tchekalarova, Jana
    Atanasova, Dimitrinka
    Kortenska, Lidia
    Atanasova, Milena
    HORMONES AND BEHAVIOR, 2019, 107 : 11 - 19
  • [45] Metformin restores cognitive dysfunction and histopathological deficits in an animal model of sporadic Alzheimer's disease
    Rabieipoor, Saghar
    Zare, Meysam
    Ettcheto, Miren
    Camins, Antoni
    Javan, Mohammad
    HELIYON, 2023, 9 (07)
  • [46] Liquiritigenin attenuates the learning and memory deficits in an amyloid protein precursor transgenic mouse model and the underlying mechanisms
    Liu, Rui Ting
    Tang, Jin Tian
    Zou, Li Bo
    Fu, Jie Ying
    Lu, Qiu Jun
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2011, 669 (1-3) : 76 - 83
  • [47] Humanin attenuates Alzheimer-like cognitive deficits and pathological changes induced by amyloid β-peptide in rats
    Chai, Gao-Shang
    Duan, Dong-Xiao
    Ma, Rong-Hong
    Shen, Jian-Ying
    Li, Hong-Lian
    Ma, Zhi-Wei
    Luo, Yu
    Wang, Lu
    Qi, Xin-Hua
    Wang, Qun
    Wang, Jian-Zhi
    Wei, Zelan
    Mousseau, Darrell D.
    Wang, Li
    Liu, Gongping
    NEUROSCIENCE BULLETIN, 2014, 30 (06) : 923 - 935
  • [48] Humanin attenuates Alzheimer-like cognitive deficits and pathological changes induced by amyloid β-peptide in rats
    Gao-Shang Chai
    Dong-Xiao Duan
    Rong-Hong Ma
    Jian-Ying Shen
    Hong-Lian Li
    Zhi-Wei Ma
    Yu Luo
    Lu Wang
    Xin-Hua Qi
    Qun Wang
    Jian-Zhi Wang
    Zelan Wei
    Darrell D.Mousseau
    Li Wang
    Gongping Liu
    NeuroscienceBulletin, 2014, 30 (06) : 923 - 935
  • [49] Amelioration of amyloid-β-induced deficits by DcR3 in an Alzheimer's disease model
    Liu, Yi-Ling
    Chen, Wei-Ting
    Lin, Yu-Yi
    Lu, Po-Hung
    Hsieh, Shie-Liang
    Cheng, Irene Han-Juo
    MOLECULAR NEURODEGENERATION, 2017, 12
  • [50] Humanin attenuates Alzheimer-like cognitive deficits and pathological changes induced by amyloid β-peptide in rats
    Gao-Shang Chai
    Dong-Xiao Duan
    Rong-Hong Ma
    Jian-Ying Shen
    Hong-Lian Li
    Zhi-Wei Ma
    Yu Luo
    Lu Wang
    Xin-Hua Qi
    Qun Wang
    Jian-Zhi Wang
    Zelan Wei
    Darrell D. Mousseau
    Li Wang
    Gongping Liu
    Neuroscience Bulletin, 2014, 30 : 923 - 935